Metabolic syndrome and autoimmune diabetes: Action LADA 3

Diabetes Care

Volumn 32, Issue 1, 2009, Pages 160-164

  Hawa, Mohammed I ^a   Thivolet, Charles ^b   Mauricio, Didac ^c   Alemanno, Irene ^a   Cipponeri, Elisa ^a   Collier, David ^a   Hunter, Steven ^d   Buzzetti, Raffaella ^e   De Leiva, Alberto ^c   Pozzilli, Paolo ^a,f   Leslie, Richard David G ^a  

^a Instituteof Cell and Molecular Science   (United Kingdom)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d ROYAL VICTORIA HOSPITAL   (United Kingdom)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DIABETES; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

ADULT; AGE OF ONSET; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY SIZE; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EUROPE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SEX CHARACTERISTICS; TRIGLYCERIDES; URBAN POPULATION;

EID: 64549152124     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1419     Document Type: Article

References (26)

1. Leslie RD, Williams R, Pozzilli P: Type 1 diabetes and latent autoimmune diabetes in adults (LADA): one end of the rainbow. J Clin Endocrinol Metab 91:1654 -1659, 2006
2. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC: Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47:1661-1667, 2004
3. Hawa MI, Bonfanti R, Valeri C, Delli Castelli M, Beyan H, Leslie RD: No evidence for genetically determined alteration in insulin secretion or sensitivity predisposing to type 1 diabetes: a study of identical twins. Diabetes Care 28:1415-1418, 2005.
4. Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP, Diabetes Prevention Trial-Type 1 Study Group: Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 30: 2314-2320, 2007
5. Bingley PJ, Mahon JL, Gale EA, European Nicotinamide Diabetes Intervention Trial Group: Insulin resistance and progression
6. to type 1 diabetes in the European Nico-tinamide Diabetes Intervention Trial (ENDIT). Diabetes Care 31:146-150, 2008
7. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
8. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
9. Leslie RD, Kolb H, Schloot NC, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Sarti C, Thivolet C, Hadden D, Hunter S, Schernthaner G, Scherbaum W, Williams R, Pozzilli P: Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev 24:511-519, 2008
10. Hosszufalusi N, Vatay A, Rajczy K, Pro-haszkaZ, Pozsonyi E, HorvathL, Grosz A, Gero L, Madacsy L, Romics L, Karadi I, Fust G, Panczel P: Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression. Diabetes Care 26:452-457, 2003
11. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bot-tazzo GF, Holman R: UKPDS 25: autoan-tibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350:1288-1293, 1997
12. Leslie RD, Delli Castelli M: Age-dependent influences on the origins of autoimmune diabetes: evidence and implications. Diabetes 53:3033-3040, 2004
13. Hawa MI, FavaD,Medici F,Deng YJ, Not-kins AL, De Mattia G, Leslie RD: Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and poly-clonality. Diabetes Care 23:228 -2233, 2000
14. Bingley PJ, Bonifacio E, Mueller PW: Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 52:1128-1136, 2003
15. Kahn R: Metabolic syndrome-what is the clinical usefulness? Lancet 371:1892- 1893, 2008
16. Carlsson S, Midthjell K, Tesfamarian MY, Grill V: Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Trøndelag Health Study. Diabetologia 50:55-58, 2007
17. Tuomi T, Carlsson A, Li H, Isomaa B, Mi-ettinen A, Nilsson A, Nisse'n M, Ehrn-ström BO, Forse'n B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC: Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150-157, 1999
18. Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D: Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care 26:138-143, 2003
19. Pietropaolo M, Barinas-Mitchell E, Kuller LH: The heterogeneity of diabetes: unravelling a dispute: is systemic inflammation related to islet autoimmunity? Diabetes 56:1189-1197, 2007
20. Zinman B, Kahn SE, Haffner SM, O'Neill MC, Heise MA, Freed MI: Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 53:3193-3200, 2004
21. Buzzetti R, Di Pietro S, Giaccari A, Petrone A, Locatelli M, Suraci C, Capizzi M, Arpi ML, Bazzigaluppi E, Dotta F, Bosi E, Non Insulin Requiring Autoimmune Diabetes Study Group: High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 30:932-938, 2007
22. Rosa'rio PW, Reis JS, Amim R, Fagundes TA, Calsolari MR, Silva SC, Purisch S: Comparison of clinical and laboratory characteristics between adult-onset type 1 diabetes and latent autoimmune diabetes in adults. Diabetes Care 28:1803-1804, 2005
23. Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, Waden J, Ronnback M, Rosengard-Barlund M, Bjorkesten CG, Taskinen MR, Groop PH, FinnDiane Study Group. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28:2019-2024, 2005
24. Kilpatrick ES, Rigby AS, Atkin SL: Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial. Diabetes Care 30:707-712, 2007
25. Cervin C, Lyssenko V, Bakhtadze E, Lindholm E, Nilsson P, Tuomi T, Cilio CM, Groop L: Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 57:1433-1437, 2008
26. Brophy S Yderstraede Y, Mauricio D, Hunter S, Hawa MI, Pozzilli P, Schern-thaner G, Schloot N, Buzzetti R, Davies H, Leslie RD, Williams R: Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diabetes Care 31:439-441, 2008